FOK1 and APA1 Gene Polymorphism Among Polycystic Ovary Syndrome: A Prospective Cohort Study
- PMID: 40390930
- PMCID: PMC12085472
- DOI: 10.1007/s13224-024-02024-1
FOK1 and APA1 Gene Polymorphism Among Polycystic Ovary Syndrome: A Prospective Cohort Study
Abstract
Background: Vitamin D receptor (VDR) regulates insulin sensitivity, lipid metabolism and hormone balance in women. There are contrasting opinions on influence of VDR gene polymorphism for PCOS predisposition. Therefore, the present study investigated associations between VDR polymorphism (FOK1 and APA1) and PCOS phenotype as well as related biochemical and clinical parameters.
Methods: A total 240 female participants were enrolled in the study which consists of 120 women with PCOS and 120 control in group. We collected 5 ml of blood from each participant from which 3 ml was used for biochemical analysis and 2 ml was used to investigate genetic polymorphism in VDR genes via PCR-RFLP. Chi-square test, one-way ANOVA and Kruskal-Wallis test were used for the data analysis.
Results: We found that polymorphism in FOK1 and APA1 genotypes were significantly associated with the body mass index (BMI), high-density lipoprotein (HDL), prolactin level and fasting blood sample (FBS), total cholesterol, triglyceride, HDL level respectively among PCOS patients (p-value < 0.05). Similarly, APA1 polymorphism was also associated with the hip-waist ratio, FBS, HDL, LDL and LDL/HDL ratio, estradiol and prolactin level in control group (p < 0.05). However, we didn't find any difference in the genotypic distribution of the FOK1 and APA1 gene polymorphs among the PCOS and controls group (p > 0.05).
Conclusion: The polymorphism in FOK1 and APA1 genes can indirectly alter the biochemical parameter and hormonal balance in body which might contribute to the development of PCOS. Dyslipidemia and hormonal imbalance must be ruled out in relation to VDR gene polymorphism in PCOS.
Keywords: Gene; Ovary; Polymorphism; Vitamin D receptor; Women.
© Federation of Obstetric & Gynecological Societies of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Similar articles
-
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.Anticancer Res. 2009 Sep;29(9):3511-36. Anticancer Res. 2009. PMID: 19667145
-
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD009526. doi: 10.1002/14651858.CD009526.pub2. Cochrane Database Syst Rev. 2017. PMID: 29125183 Free PMC article.
-
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044. Hum Reprod. 2017. PMID: 28333286
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6. Cochrane Database Syst Rev. 2017. PMID: 29183107 Free PMC article.
References
-
- Mehreen TS, Ranjani H, Kamalesh R, Ram U, Anjana RM, Mohan V. Prevalence of polycystic ovarian syndrome among adolescents and young women in India. J Diabetol. 2021;12(3):319–25.